Evidence map›Paper›PMID 21955121›Full record

ArticleJournal of proteome research2011

Data analysis strategy for maximizing high-confidence protein identifications in complex proteomes such as human tumor secretomes and human serum.

Huan Wang, Hsin-Yao Tang, Glenn C Tan, David W Speicher

Abstract read
In one paragraph

Article in Journal of proteome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huan WangThe Wistar Institute, Philadelphia, PA, USA.
Hsin-Yao Tang
Glenn C Tan
David W Speicher

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Maureen E. Murphy · 1985 to 2026
$75.9M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Identification of Ovarian Cancer Plasma BiomarkersR01CA131582 · NCI · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 2009 to 2018
$4.1M
Discovery and validation of novel serological biomarkers of colon cancerR01CA120393 · NCI · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 2006 to 2010
$1.9M
NCI NIH HHS CA009171NCI NIH HHS CA010815NCI NIH HHS CA120393NCI NIH HHS CA131582NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA120393NCI NIH HHS R01 CA131582NCI NIH HHS T32 CA009171
6 · The paper itself

Abstract

Detection of biologically interesting, low-abundance proteins in complex proteomes such as serum typically requires extensive fractionation and high-performance mass spectrometers. Processing of the resulting large data sets involves trade-offs between confidence of identification and depth of protein coverage; that is, higher stringency filters preferentially reduce the number of low-abundance proteins identified. In the current study, an alternative database search and results filtering strategies were evaluated using test samples ranging from purified proteins to ovarian tumor secretomes and human serum to maximize peptide and protein coverage. Full and partial tryptic searches were compared because substantial numbers of partial tryptic peptides were observed in all samples, and the proportion of partial tryptic peptides was particularly high for serum. When data filters that yielded similar false discovery rates (FDR) were used, full tryptic searches detected far fewer peptides than partial tryptic searches. In contrast to the common practice of using full tryptic specificity and a narrow precursor mass tolerance, more proteins and peptides could be confidently identified using a partial tryptic database search with a 100 ppm precursor mass tolerance followed by filtering of results using 10 ppm mass error and full tryptic boundaries.

Indexed as

Data Interpretation, StatisticalAmino Acid SequenceBlood ProteinsFalse Positive ReactionsFemaleHumansMolecular Sequence DataNeoplasm ProteinsOvarian NeoplasmsPeptide FragmentsProtein Processing, Post-TranslationalProteolysisProteomeTandem Mass SpectrometryBlood ProteinsNeoplasm ProteinsPeptide FragmentsProteome

Identifiers

PMID21955121
PMCPMC3221390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.